Metraipolis › archive › dc_2f0753d021d1

Abiraterone-Associated Renal Damage in Patients with Advanced Prostate Cancer as a Risk Factor for Mortality and Chronic Kidney Disease — Europe PMC PMID:41226956

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41226956
DOI
10.3390/jcm14217559
License (as archived)
solo-consultazione
Archived
2026-11-09T01:45:16.964Z
SHA-256 of the archived text
d48747ebecb51e4e747124c3feac047da19c93d83f903111fe4dcd8fcf7b0312
Stable URL of this page
https://metraipolis.com/documento/dc_2f0753d021d1

How to cite

Abiraterone-Associated Renal Damage in Patients with Advanced Prostate Cancer as a Risk Factor for Mortality and Chronic Kidney Disease — Europe PMC PMID:41226956 — Europe PMC (en), https://europepmc.org/article/MED/41226956 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2f0753d021d1 (Metraipolis archive dc_2f0753d021d1, sha256 d48747ebecb51e4e747124c3feac047da19c93d83f903111fe4dcd8fcf7b0312)
BibTeX
@misc{dc2f0753d021d1,
  title = {Abiraterone-Associated Renal Damage in Patients with Advanced Prostate Cancer as a Risk Factor for Mortality and Chronic Kidney Disease — Europe PMC PMID:41226956},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41226956},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2f0753d021d1; sha256 d48747ebecb51e4e747124c3feac047da19c93d83f903111fe4dcd8fcf7b0312},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41226956. Agents can read the archived copy with the MCP tool read_document.